Top Movers: VIVUS (NASDAQ:VVUS), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals (NASDAQ:ARIA), MannKind Corporation (NASDAQ:MNKD), MONITISE PLC (OTCMKTS:MONIF)

VIVUS, Inc. (NASDAQ:VVUS)’s shares dropped 1.89% to $5.18. The company on June 12 announced that it has filed a lawsuit in the U.S. District Court for the District of New Jersey against Actavis Laboratories FL, Inc., Actavis, Inc., and Actavis PLC, collectively referred to as Actavis. VIVUS, Inc. (NASDAQ:VVUS), weekly performance is -0.19%. On last trading day company shares ended up $5.20. Analysts mean target price for the company is $7.33. VIVUS, Inc. (NASDAQ:VVUS), distance from 50-day simple moving average (SMA50) is 2.64%.

Shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), saw a significant drop in short interest in the month of May. As of May 30th, there was short interest totalling 43,940,567 shares, a drop of 4.6% from the May 15th total of 46,073,021 shares, Analyst Ratings Net reports. Based on an average daily volume of 3,705,182 shares, the days-to-cover ratio is presently 11.9 days. Currently, 20.1% of the company’s stock are short sold. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), advanced 0.32% in last trading session and ended the day on $6.22. ARNA, Gross Margin is 93.70% and its return on assets is -8.10%. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), quarterly performance is -4.60%.

Shares of Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), saw a large decline in short interest during the month of May. As of May 30th, there was short interest totalling 40,057,180 shares, a decline of 3.7% from the May 15th total of 41,604,152 shares, American Banking and Market News reports. Based on an average daily volume of 6,842,236 shares, the days-to-cover ratio is currently 5.9 days. Currently, 22.2% of the shares of the stock are sold short. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), shares moved up 2.66% in last trading session and was closed at $6.55, while trading in range of $6.28 – 6.57. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), year to date (YTD) performance is -3.96%.

MannKind Corporation (NASDAQ:MNKD), VP Diane Palumbo unloaded 17,902 shares of the company’s stock on the open market in a transaction dated Monday, June 16th. The stock was sold at an average price of $10.59, for a total transaction of $189,582.18. Following the completion of the transaction, the vice president now directly owns 140,956 shares in the company, valued at approximately $1,492,724. MannKind Corporation (NASDAQ:MNKD), ended the last trading day at $10.54. Company weekly volatility is calculated as 4.44% and price to cash ratio as 114.41. MannKind Corporation (NASDAQ:MNKD), showed a positive weekly performance of 1.84%.

On June 09, 2014, MONITISE PLC (OTCMKTS:MONIF), said it has signed a new partnership agreement with Turkey’s Yapi Kredi Bank, to offer Nuvo, its ‘branchless banking’ service with mobile commerce capabilities. MONITISE PLC (OTCMKTS:MONIF), on last trading day company shares ended up $1.03.